CLINICAL_TRIALS
research
· 2017-02-17
Clinical Trial Update: Intravesical Botulinum Toxin A Injections in Treatment of Interstitial Cystitis Refractory to Conventional Treatment [Phase 2]
Summary
A Phase 2 clinical trial evaluating intravesical Botulinum toxin A injections for interstitial cystitis refractory to conventional treatment has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Buddhist Tzu Chi General Hospital | Conditions: Interstitial Cystitis | Phase 2 | Status: COMPLETED